Who Exports Ofloxacin from India — 1094 Suppliers Behind a $295.2M Market
India's ofloxacin export market is supplied by 1094 active exporters who collectively shipped $295.2M across 15,000 shipments. DR.REDDY'S LABORATORIES LTD leads with a 14.2% market share, followed by DR REDDYS LABORATORIES LIMITED and MACLEODS PHARMACEUTICALS LTD. The top 5 suppliers together control 41.2% of total export value, reflecting a moderately competitive market structure.
Top Ofloxacin Exporters from India — Ranked by Export Value
DR.REDDY'S LABORATORIES LTD is the leading ofloxacin exporter from India, holding a 14.2% share of the $295.2M market across 15,000 shipments from 1094 exporters. The top 5 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MICRO LABS LIMITED — collectively control 41.2% of total export value, indicating a competitive market. Individual shares are: DR.REDDY'S LABORATORIES LTD (14.2%), DR REDDYS LABORATORIES LIMITED (10.1%), MACLEODS PHARMACEUTICALS LTD (7.3%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (6.7%), MICRO LABS LIMITED (2.8%).
Top Ofloxacin Exporters from India
Ranked by export value · 1094 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $42.0M | 2 | 14.2% |
| 2 | DR REDDYS LABORATORIES LIMITED CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN 500 MG TABLETS 10X10SLEVORIDE | $29.8M | 1 | 10.1% |
| 3 | MACLEODS PHARMACEUTICALS LTD CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROFLOXACIN 500 MG TABLETS 10X10SLEVORIDE | $21.5M | 33 | 7.3% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLECIPROTAB 500-CIPROFLOXACIN TABLETS USP 5 | $19.9M | 20 | 6.7% |
| 5 | MICRO LABS LIMITED CIPROFLOXACIN 500 MG TABLETS 10X10SAXOFLOX-500 (CIPROFLOXACIN TABLETS BP 50MICROLUSS (CIPROFLOXACIN TABLETS USP 500 | $8.4M | 33 | 2.8% |
| 6 | AUROBINDO PHARMA LTD CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLEOFLOXACIN 200 MG TABLETS 1X10S (50000 P | $7.2M | 12 | 2.4% |
| 7 | SENTISS PHARMA PRIVATE LIMITED LEVOMAC IV 1X100MLLEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/CIPROFLOXACIN -AGIO TABLETS 500MGCIPROF | $6.3M | 7 | 2.1% |
| 8 | MEDOPHARM CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROSCOT-500 BL. CIPROFLOXACINCIPROTAB 500-CIPROFLOXACIN TABLETS USP 5 | $6.2M | 15 | 2.1% |
| 9 | MANKIND PHARMA LIMITED CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | $6.1M | 3 | 2.1% |
| 10 | FDC LIMITED CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1CIPROSCOT-500 BL. CIPROFLOXACINCIPROFLOXACIN TABLETS 500MG (WHITE,ELONG | $6.0M | 5 | 2.0% |
| 11 | MEDNEXT BIOTECH LIMITED CIPROFLOXACIN TABLETS BP 500MGEACH FILM | $5.2M | 4 | 1.8% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LTD CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLECIPROTAB 500-CIPROFLOXACIN TABLETS USP 5 | $4.5M | 8 | 1.5% |
| 13 | MEDCELL PHARMA LEVORIDECIPRONIKA INJECTION CIPROFLOXACIN 200MG/LEVOFLOXACIN TABLETS 500MG (EACH FILM-CO | $3.7M | 4 | 1.3% |
| 14 | ZYPHER LIFESCIENCES PRIVATE LIMITED | $3.7M | 1 | 1.3% |
| 15 | ZYDUS LIFESCIENCES LIMITED CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLEOFLOXACIN 200 MG TABLETS 1X10S (50000 P | $3.4M | 14 | 1.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ofloxacin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. | Approved | Yes | Yes | 7 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 7 ANDAs. |
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | 10 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 10 ANDAs. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | 59 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 59 ANDAs. |
| Aurobindo Pharma Ltd. | Approved | Yes | Yes | 41 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 41 ANDAs. |
| Macleods Pharmaceuticals Ltd. | Approved | Yes | Yes | 10 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 10 ANDAs. |
| Micro Labs Limited | Approved | Yes | Yes | 11 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 11 ANDAs. |
| Mankind Pharma Limited | Approved | Yes | Yes | 11 | FDA-approved manufacturer with WHO and EU GMP certifications; holds 11 ANDAs. |
| FDC Limited | Approved | Yes | Yes | Not specified | FDA-approved manufacturer with WHO and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 8 leading Ofloxacin exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ofloxacin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, located in Telangana, is renowned as India's "Bulk Drug Capital." The city hosts numerous Active Pharmaceutical Ingredient (API) manufacturers, contributing significantly to the production of bulk drugs like Ofloxacin. Companies such as Aurobindo Pharma and Dr. Reddy's Laboratories, both headquartered in Hyderabad, are key players in this sector. Their extensive manufacturing facilities and adherence to international quality standards have positioned Hyderabad as a critical hub for API production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. This region is home to companies like Alembic Pharmaceuticals, which specializes in the production of finished dosage forms, including Ofloxacin tablets and injectables. The presence of such established firms underscores the region's capacity for high-quality pharmaceutical manufacturing, catering to both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a vital export gateway for Indian pharmaceuticals. Mumbai, being a major port city, facilitates the export of pharmaceutical products to over 200 countries. Companies like Sun Pharmaceutical Industries, headquartered in Mumbai, leverage this strategic location to distribute products like Ofloxacin globally. The region's robust infrastructure and proximity to international shipping routes enhance its role in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh have emerged as significant pharmaceutical manufacturing zones, primarily due to favorable tax incentives offered by the state government. This region attracts numerous pharmaceutical companies seeking cost-effective production solutions. The tax benefits, coupled with a supportive industrial environment, have led to the establishment of several manufacturing units producing a range of pharmaceutical products, including antibiotics like Ofloxacin.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications from regulatory bodies such as the US FDA and WHO.
- Evaluate Logistics Infrastructure: Consider the proximity of manufacturing facilities to major ports and transportation networks to optimize supply chain efficiency.
- Monitor Market Dynamics: Stay informed about regional policies, tax incentives, and industry developments that may impact production costs and supplier reliability.
By strategically sourcing from India's diverse pharmaceutical clusters, companies can enhance their supply chain resilience and ensure a steady supply of high-quality Ofloxacin products.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ofloxacin exporters from India
Dr. Reddy's Laboratories Ltd. — Dr. Reddy's to acquire Mayne Pharma's U.S. generic portfolio
Dr. Reddy's Laboratories announced a definitive agreement to acquire Mayne Pharma's U.S. generic prescription product portfolio, comprising approximately 45 commercial products, four pipeline products, and 40 approved non-marketed products. The acquisition aims to enhance Dr. Reddy's presence in the U.S. generic market, particularly in women's health. - IMPACT: This acquisition is expected to strengthen Dr. Reddy's U.S. market position, potentially increasing Ofloxacin exports to the region.
Impact: This acquisition is expected to strengthen Dr. Reddy's U.S. market position, potentially increasing Ofloxacin exports to the region.
Common Questions — Ofloxacin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ofloxacin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, DR.REDDY'S LABORATORIES LTD leads with 74 recorded shipments worth $42.0M. DR REDDYS LABORATORIES LIMITED (26 shipments) and MACLEODS PHARMACEUTICALS LTD (243 shipments) are also established high-volume exporters.
Q How many ofloxacin manufacturers are there in India?
India has 1094 active ofloxacin exporters with a combined export market of $295.2M across 15,000 shipments to 180 countries. The top 5 suppliers hold 41.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ofloxacin from India?
Average FOB unit price: $13.41 per unit, ranging from $0.01 to $10480.89. Average shipment value: $19.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 1094 verified Indian exporters of Ofloxacin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 180 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
1094 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists